PVLA

Palvella Therapeutics
PVLA

Upgrade to unlock
Buy
Hold
Sell

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$136
44% upside
High target

9 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Stifel
Stifel
Annabel Samimy
100% 1-yr PVLA win rate
24 Nov ‘25 7 days ago
Raymond James
Raymond James
Ryan Deschner
100% 1-yr PVLA win rate
19 Nov ‘25 13 days ago
Canaccord Genuity
Canaccord Genuity
Whitney Ijem
71% 1-yr PVLA win rate
13 Nov ‘25 18 days ago
Chardan Capital
Chardan Capital
Geulah Livshits
100% 1-yr PVLA win rate
13 Nov ‘25 18 days ago
Truist Securities
Truist Securities
Danielle Brill
100% 1-yr PVLA win rate
10 Nov ‘25 21 days ago
TD Cowen
TD Cowen
Ritu Baral
100% 1-yr PVLA win rate
6 Nov ‘25 25 days ago
Cantor Fitzgerald
Cantor Fitzgerald
Josh Schimmer
100% 1-yr PVLA win rate
6 Nov ‘25 25 days ago
HC Wainwright & Co
HC Wainwright & Co
Andrew Fein
89% 1-yr PVLA win rate
6 Nov ‘25 26 days ago
Oppenheimer
Oppenheimer
Trevor Allred
100% 1-yr PVLA win rate
9 Sep ‘25 2 months ago